Suppressive Effects of Tea Catechins on Breast Cancer

Evaluation of breast cancer risk associated with tea consumption by menopausal and estrogen receptor status among Chinese women in Hong Kong

(2016) Mengjie Li et al.   Cancer Epidemiology

Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo , in vitro and ex vivo studies

(2016) Joana F. Fangueiro et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Combinational enhancing effects of formulation and encapsulation on digestive stability and intestinal transport of green tea catechins

(2016) Yu-Ra Son et al.   JOURNAL OF MICROENCAPSULATION

Stability of (−)-epigallocatechin gallate and its activity in liquid formulations and delivery systems

(2016) Olga Krupkova et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Epigallocatechin gallate and mitochondria—A story of life and death

(2016) Marcos Roberto de Oliveira et al.   PHARMACOLOGICAL RESEARCH

Monitoring volatile compound profiles and chemical compositions during the process of manufacturing semi-fermented oolong tea

(2016) S. Y. Lin et al.   JOURNAL OF HORTICULTURAL SCIENCE & BIOTECHNOLOGY

Growth inhibition and apoptosis in cancer cells induced by polyphenolic compounds of Acacia hydaspica: Involvement of multiple signal transduction pathways

(2016) Tayyaba Afsar et al.   Scientific Reports

Co-delivery of hydrophobic curcumin and hydrophilic catechin by a water-in-oil-in-water double emulsion

(2015) N.P. Aditya et al.   FOOD CHEMISTRY

The catechol-O-methyltransferase inhibitor, tolcapone, increases the bioavailability of unmethylated (-)-epigallocatechin-3-gallate in mice

(2015) Sarah C. Forester et al.   Journal of Functional Foods

EGCG reverses human neutrophil elastase-induced migration in A549 cells by directly binding to HNE and by regulating α1-AT

(2015) Yilixiati Xiaokaiti et al.   Scientific Reports

The activity of catechol-O-methyltransferase (COMT) is not impaired by high doses of epigallocatechin-3-gallate (EGCG) in vivo

(2014) Mario Lorenz et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Preparation, characterization, and in vitro antitumor activity of folate conjugated chitosan coated EGCG nanoparticles

(2014) Jin Liang et al.   FOOD SCIENCE AND BIOTECHNOLOGY

Green tea (Camellia sinensis) extract inhibits both the metastasis and osteolytic components of mammary cancer 4T1 lesions in mice

(2014) Ke-Wang Luo et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Estrogen receptor beta in breast cancer

(2013) Lars-Arne Haldosén et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Synthesis of Gelatin-γ-Polyglutamic Acid-Based Hydrogel for the In Vitro Controlled Release of Epigallocatechin Gallate (EGCG) from Camellia sinensis

(2013) John Garcia et al.   Polymers

Piper betle shows antioxidant activities, inhibits MCF-7 cell proliferation and increases activities of catalase and superoxide dismutase

(2012) Noor Nazirahanie Abrahim et al.   BMC Complementary and Alternative Medicine

American Cancer Society guidelines on nutrition and physical activity for cancer prevention

(2012) Lawrence H. Kushi et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Influence of Gallate and Pyrogallol Moieties on the Intestinal Absorption of (−)-Epicatechin and (−)-Epicatechin Gallate

(2012) Tomohiko Tagashira et al.   JOURNAL OF FOOD SCIENCE

Diet and Breast Cancer

(2012) Cynthia A. Thomson   NUTRITION IN CLINICAL PRACTICE

Mechanisms for epigallocatechin gallate induced inhibition of drug metabolizing enzymes in rat liver microsomes

(2012) Zuquan Weng et al.   TOXICOLOGY LETTERS

Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor

(2011) Glenn S. Van Aller et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Green tea consumption and breast cancer risk: three recent meta-analyses

(2011) Ping Zhou et al.   BREAST CANCER RESEARCH AND TREATMENT

Green tea catechin intervention of reactive oxygen species-mediated ERK pathway activation and chronically induced breast cell carcinogenesis

(2011) K. Rathore et al.   CARCINOGENESIS

Catechin hydrate suppresses MCF-7 proliferation through TP53/Caspase-mediated apoptosis

(2011) Ali A Alshatwi   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

(–)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells

(2010) Fulvia Farabegoli et al.   BIOSCIENCE REPORTS

Epigallocatechin Gallate Suppresses Lung Cancer Cell Growth through Ras-GTPase-Activating Protein SH3 Domain-Binding Protein 1

(2010) J. H. Shim et al.   Cancer Prevention Research

Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process

(2010) Triparna Sen et al.   EUROPEAN JOURNAL OF NUTRITION

Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (−)-epigallocatechin gallate

(2010) Admire Dube et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Isolation of antioxidant catechins from green tea and its decaffeination

(2010) Jun-Jie Dong et al.   FOOD AND BIOPRODUCTS PROCESSING

Chemical and Instrumental Assessment of Green Tea Sensory Preference

(2010) Y.R. Liang et al.   INTERNATIONAL JOURNAL OF FOOD PROPERTIES

The anti-cancer effects of (−)-Epigalocathine-3-gallate on the signaling pathways associated with membrane receptors in MCF-7 cells

(2010) Yuan-Chang Hsu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Exercise, Tea Consumption, and Depression Among Breast Cancer Survivors

(2010) Xiaoli Chen et al.   JOURNAL OF CLINICAL ONCOLOGY

Synergistic epigenetic reactivation of estrogen receptor-alpha (ERalpha) by combined green tea polyphenol and histone deacetylase inhibitor in ERalpha-negative breast cancer cells

(2010) Yuanyuan Li et al.   Molecular Cancer

Is Green Tea Drinking Associated With a Later Onset of Breast Cancer?

(2009) Qi Dai et al.   ANNALS OF EPIDEMIOLOGY

Proteasome inhibition in human breast cancer cells with high catechol-O-methyltransferase activity by green tea polyphenol EGCG analogs

(2009) Congde Huo et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Green tea consumption and breast cancer risk or recurrence: a meta-analysis

(2009) Adeyemi A. Ogunleye et al.   BREAST CANCER RESEARCH AND TREATMENT

Tea Consumption and Risk of Breast Cancer

(2009) N. Kumar et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Green tea (−)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity

(2009) Yimin Zhang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study

(2008) M. Inoue et al.   CARCINOGENESIS

Coffee, tea, caffeine and risk of breast cancer: A 22-year follow-up

(2008) Davaasambuu Ganmaa et al.   INTERNATIONAL JOURNAL OF CANCER

Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women

(2008) Min Zhang et al.   INTERNATIONAL JOURNAL OF CANCER

(-)-Epigallocatechin Gallate Regulates CD3-mediated T Cell Receptor Signaling in Leukemia through the Inhibition of ZAP-70 Kinase

(2008) Jung-Hyun Shim et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Drinking Green Tea Modestly Reduces Breast Cancer Risk

(2008) Martha J. Shrubsole et al.   JOURNAL OF NUTRITION

Fyn is a novel target of (−)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation

(2007) Zhiwei He et al.   MOLECULAR CARCINOGENESIS